dc.contributor.author |
Prohászka Zoltán |
|
dc.contributor.author |
Tóth Ferenc D. |
|
dc.contributor.author |
Banhegyi Dénes |
|
dc.contributor.author |
Füst George |
|
dc.date.accessioned |
2019-01-11T12:08:14Z |
|
dc.date.available |
2019-01-11T12:08:14Z |
|
dc.date.issued |
1997 |
|
dc.identifier.citation |
pagination=296-302;
journalVolume=3;
journalIssueNumber=4;
journalTitle=PATHOLOGY AND ONCOLOGY RESEARCH; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/6387 |
|
dc.description.abstract |
In humans the HIV infection results in a chronic disease with a permanent fight
between factors controlling HIV and the escape of the virus. Fromthese control
mechanisms the present review summarizes the role betwen complement and
autoantibodies; the competition of complement and anti-HIV antibodies for binding
sites, the role of mannan-binding lectin in the susceptibility to and in the
survival after HIV infection, the contribution of complement-dependent enhancing
type antibodies to the clinical progression of HIV disease as well as the
changing pattern of some autoantibodies (mimicking MHC class II molecules,
anti-heat shock protein 60 antibodies and anti-C1q antibodies) which were found
to correlate to immunological and clinical parameters. |
|
dc.relation.ispartof |
urn:issn:1219-4956 |
|
dc.title |
Role of Complement and Antibodies in the Control and Facilitation of HIV Disease. |
|
dc.type |
Journal Article |
|
dc.date.updated |
2018-09-02T10:19:29Z |
|
dc.language.rfc3066 |
en |
|
dc.identifier.mtmt |
1233463 |
|
dc.identifier.pubmed |
11173651 |
|
dc.contributor.department |
SE/AOK/K/III. Sz. Belgyógyászati Klinika |
|
dc.contributor.institution |
Semmelweis Egyetem |
|